Okyanos Heart Institute is committed to a collaborative partnership with physicians treating patients with severe Coronary Artery Disease. Established to U.S. medical standards, the institute is built upon a foundation of science and technology to follow patients’ progress over time. This depends upon the collaborative partnership of our referring physicians and our patient registry.
Patients who are referred to Okyanos Heart Institute are rigorously screened to determine their candidacy for cell therapy. Our medical team works closely with the referring physician both pre- and post-treatment. We are committed to the construct of a detailed registry that tracks outcomes, and clinical factors over time as the field of cell therapy matures. We consider this a partnership with the medical science community at large.
For any questions pertaining to a referral, please call 1-855-OKYANOS, or email email@example.com.
To support the critical research function of Okyanos, we seek your ongoing partnership with our on-line patient registry. The objective of the registry is to capture key longitudinal data (e.g., echocardiography, stress test) post-treatment. Your participation in the registry will assist in the further progress of cardiac cell therapy and without doubt improve the quality of life for future patients suffering with heart failure. With your permission, Okyanos will send you all registry related publications.